Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Evaluation and Treatment of Patients with Lung Disease not Participating in Research Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Evaluation and Treatment of Patients with Lung Disease not Participating in Research conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Evaluation and Treatment of Patients with Lung Disease not Participating in Research Clinical research trials and Evaluation and Treatment of Patients with Lung Disease not Participating in Research medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Evaluation and Treatment of Patients with Lung Disease not Participating in Research. Evaluation and Treatment of Patients with Lung Disease not Participating in Research Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Evaluation and Treatment of Patients with Lung Disease not Participating in Research clinical trial. Test subjects typically obtain the finest healthcare available for their Evaluation and Treatment of Patients with Lung Disease not Participating in Research condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.

Home > "E" Clinical Trials Conditions > Evaluation and Treatment of Patients with Lung Disease not Participating in Research

Evaluation and Treatment of Patients with Lung Disease not Participating in Research



Evaluation and Treatment of Patients with Lung Disease not Participating in Research

For Condition: Lung Disease
Status: Recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: This study was developed in order for the professional-staff at the Pulmonary-Critical Care Medical Branch (PCCMB) of the National Heart, Lung, and Blood Institute to maintain their skills and increase their understanding of lung diseases. The study will permit PCCMB staff members to evaluate and treat patients with lung disease who do not meet the criteria for other research studies.
Details: The professional staff in the Pulmonary-Critical Care Medicine Branch (PCCMB) needs to maintain their clinical skills and to enhance their clinical knowledge. The purpose of this protocol is to permit PCCMB staff to evaluate and treat patients with pulmonary disease who do not meet the criteria for existing research protocols.
Eligibility:
Study Type:  Interventional, Training
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Patients 10 through 65 years of age with signs or symptoms of pulmonary disease of medical interest to the professional staff of PCCMB will be eligible for participation in this protocol. Only standard diagnostic procedures and conventional therapy will be performed. Patients will not be subjected to any research procedures. EXCLUSION CRITERIA: Patients without symptoms of pulmonary disease will be excluded from this protocol.
Total Enrollment: 9999

Location and Contact Information:

National Heart, Lung and Blood Institute (NHLBI) *Recruiting*
Bethesda,  Maryland,  20892
United States
Recruiting Patient  and Public Liaison Office 1-800-411-1222


Additional Information:
Study ID Numbers:  970061;  97-H-0061
Study Start Date: January 7, 1997
Record last reviewed: December 8, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001621

Other Lung Disease Studies:
1. Effects of Endotoxin in Normal Human Volunteers

2. An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF

3. Biomarkers of Benzene Exposure in Inner City Residents

4. Segmental Bronchoalveolar Lavage

5. A Randomized, Double-Blind, Three-arm, Phase 3b Study Comparing the Safety and efficacy of Interferon gamma-1b with Azatioprine, and Azathioprine Alone in Patients with IPF Receiving Prednisone

Related Studies:

Other Lung Disease Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials

Evaluation and Treatment of Patients with Lung Disease not Participating in Research
Modify your Search

  Other Lung Disease Clinical Trials
  Other Maryland Clinical Trials
  Other Bethesda Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103